Roth MKM analyst Jeff Martin reiterates a Buy rating and $224 price target on OSI Systems (OSIS), telling investors that ...
Roth MKM lowered the firm’s price target on Emeren (SOL) to $2 from $3 and keeps a Buy rating on the shares following a Q4 miss and “weak” 2025 ...
In a report released today, Craig Irwin from Roth MKM reiterated a Buy rating on Propel Holdings Inc (PRL – Research Report), with a price ...
19h
Asianet Newsable on MSNThis Small-Cap Quantum Computing Stock Remains On Track To Extend Week's 33% Gain: Retail's In Excited StateD-Wave Quantum, Inc. (QBTS) stock has bucked the broader market downturn seen this week thanks to two key catalysts. The ...
About ROTH MKM ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors.
Roth Capital issued their Q1 2025 earnings estimates for Fortress Biotech in a research report issued on Tuesday, March 11th. Roth Capital analyst J. Wittes forecasts that the biopharmaceutical ...
Stock analysts at Roth Capital decreased their Q1 2025 earnings estimates for Ayr Wellness in a research report issued to clients and investors on Monday, March 10th. Roth Capital analyst W. Kirk now ...
In a report released today, Sean McGowan from Roth MKM maintained a Buy rating on Groupon (GRPN – Research Report), with a price target of $21.00. The company’s shares closed ...
Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on Longeveron (LGVN – Research Report) today and set a price target of $10.00. The company’s shares closed today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results